Exposure to GA increased the levels of TRIB3 in breast and prostate cancer cell lines (Fig. 3A,B; Fig. S3A), as did exposure to the 2-D08 SUMO inhibitor (Fig. 3C,D). Here, TRIB3 is linked to prostate carcinoma.